Aims and Objectives: To determine 1) the incidence of lens-induced glaucoma. 2) the more prevalent type of LIG. and 3) Visual outcome following surgical management of LIG. Material and Methods: 50 patients of lens-induced glaucoma, who presented in OPD of Regional Institute of Ophthalmology, were included in the study. All patients were admitted and managed in indoor wards. Informed and written consents were taken. A detailed history and a thorough ocular examination was done. Surgical correction was done by SICS or Phacoemulsification or triple procedures operations. Results: A standardized proforma was used to compile data and it was analyzed statistically using Chi-square test and Probability value. The incidence of LIG was found to be 0.174 among all OPD attendees. Phacomorphic glaucoma (58%) was found to be the highest followed by phacolytic glaucoma (32%). No significant association with respect to sex and age of the cases was found. The presenting symptoms varied in severity and were directly proportional to the degree of rise of IOP. 38% of cases in our study achieved best corrected visual acuity of 6/9 and 28% achieved 6/12 acuity at the end of 6 weeks. Visual outcome was found to be better for cases with early detection and treatment. Conclusion: The mainstay to prevent and treat LIG is early diagnosis and treatment of cataract. Delayed treatment of LIG may result in poor visual outcome. Keywords: LIG, IOP, Phacomorphic glaucoma, Phacolytic glaucoma, SICS, Phacoemulsification.
Abstract:Aim: To study the incidence of lens induced glaucoma (LIG)
Aim: To determine the various ocular manifestations of SLE for early diagnosis, prompt initiation of therapy and better prognosis of SLE cases. A total of 50 diagnosed patients of SLE attending RIO a Materials And Methods: nd department of Dermatology, GMCH were selected for the study. Detailed history and a thorough ocular examination was performed. Laboratory investigations including R/E blood, ESR, RBS, R/E urine, 24 hours urinary protein, RFT and ANA were done. Results And Observations: Incidence of ocular manifestations of SLE was 70%. The mean age of presentation was 32.2 years. The female: male was 11.5:1. The median duration of illness was 1.75 years. The commonest systemic involvement was hematological(90%), followed by cutaneous(64%), musculoskeletal(60%), renal(42%), serosal(4%), neurological(2%). 72% had SLEDAI score ≤10 and 28% had >10. Anterior segment involvement(58%) is more than posterior segment(12%). Common anterior segment manifestations were Keratoconjunctivitis sicca, PSC, eyelid lesions, ulcerative blepheritis, subconjunctival haemorrhage, periorbital oedema, PUK, episcleritis. Posterior segment manifestations were lupus retinopathy, hypertensive retinopathy, CSCR, CRVO, optic atrophy and pigmentary maculopathy. 56% were on steroid therapy, 36% were on steroid+HCQS and 8% were on steroid+cyclophosphamide. SLE is a multisyst Conclusion: em disease with varied manifestations and diagnosis depends upon careful evaluation of all the systems including the eye. The ophthalmologist may play an important role in the care of the SLE patients, since ocular inammatory lesions may precede potentially serious extraocular disease and may guide towards the diagnosis.
A 64-year male came for treatment of a lesion on his eyelid. Approximately 10 years earlier, he had developed a small blackish mass on his right lower eyelid, which was gradually increasing in size along the infra-orbital crease. It is associated with blackish discharge. Laboratory tests were normal; medical history and family history were unremarkable. Incisional biopsy shows strings of stratified squamous epithelium, proliferative basal cells, and scattered melanin pigmentation. The tumor was completely excised, and the defect is reconstructed with modified island pedicle advancement cheek flap and sent for HPE examination. It is a powerful technique for reconstruction with minimal complication.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.